Suppr超能文献

相似文献

1
Diastolic dysfunction in familial hypertrophic cardiomyopathy transgenic model mice.
Cardiovasc Res. 2009 Apr 1;82(1):84-92. doi: 10.1093/cvr/cvp016. Epub 2009 Jan 15.
2
Prolonged Ca2+ and force transients in myosin RLC transgenic mouse fibers expressing malignant and benign FHC mutations.
J Mol Biol. 2006 Aug 11;361(2):286-99. doi: 10.1016/j.jmb.2006.06.018. Epub 2006 Jun 27.
4
Discrete effects of A57G-myosin essential light chain mutation associated with familial hypertrophic cardiomyopathy.
Am J Physiol Heart Circ Physiol. 2013 Aug 15;305(4):H575-89. doi: 10.1152/ajpheart.00107.2013. Epub 2013 Jun 7.
9
Hypertrophic cardiomyopathy associated Lys104Glu mutation in the myosin regulatory light chain causes diastolic disturbance in mice.
J Mol Cell Cardiol. 2014 Sep;74:318-29. doi: 10.1016/j.yjmcc.2014.06.011. Epub 2014 Jun 30.
10
E22K mutation of RLC that causes familial hypertrophic cardiomyopathy in heterozygous mouse myocardium: effect on cross-bridge kinetics.
Am J Physiol Heart Circ Physiol. 2006 Nov;291(5):H2098-106. doi: 10.1152/ajpheart.00396.2006. Epub 2006 Jun 2.

引用本文的文献

2
Experimental Models of Hypertrophic Cardiomyopathy: A Systematic Review.
JACC Basic Transl Sci. 2025 Apr;10(4):511-546. doi: 10.1016/j.jacbts.2024.10.017. Epub 2025 Jan 15.
4
Cardiac Sarcomere Signaling in Health and Disease.
Int J Mol Sci. 2022 Dec 19;23(24):16223. doi: 10.3390/ijms232416223.
6
Understanding the molecular basis of cardiomyopathy.
Am J Physiol Heart Circ Physiol. 2022 Feb 1;322(2):H181-H233. doi: 10.1152/ajpheart.00562.2021. Epub 2021 Nov 19.
8
Improving characterization of hypertrophy-induced murine cardiac dysfunction using four-dimensional ultrasound-derived strain mapping.
Am J Physiol Heart Circ Physiol. 2021 Jul 1;321(1):H197-H207. doi: 10.1152/ajpheart.00133.2021. Epub 2021 Jun 4.
9
Regulatory Light Chains in Cardiac Development and Disease.
Int J Mol Sci. 2021 Apr 21;22(9):4351. doi: 10.3390/ijms22094351.
10
To lie or not to lie: Super-relaxing with myosins.
Elife. 2021 Feb 10;10:e63703. doi: 10.7554/eLife.63703.

本文引用的文献

2
Regulatory light chain mutations associated with cardiomyopathy affect myosin mechanics and kinetics.
J Mol Cell Cardiol. 2009 Jan;46(1):108-15. doi: 10.1016/j.yjmcc.2008.09.126. Epub 2008 Sep 27.
3
Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics.
J Cardiovasc Electrophysiol. 2008 Jan;19(1):104-10. doi: 10.1111/j.1540-8167.2007.00965.x. Epub 2007 Oct 4.
4
Myosin regulatory light chain E22K mutation results in decreased cardiac intracellular calcium and force transients.
FASEB J. 2007 Dec;21(14):3974-85. doi: 10.1096/fj.07-8630com. Epub 2007 Jul 2.
5
Prolonged Ca2+ and force transients in myosin RLC transgenic mouse fibers expressing malignant and benign FHC mutations.
J Mol Biol. 2006 Aug 11;361(2):286-99. doi: 10.1016/j.jmb.2006.06.018. Epub 2006 Jun 27.
7
Altered intracellular Ca2+ handling in heart failure.
J Clin Invest. 2005 Mar;115(3):556-64. doi: 10.1172/JCI24159.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验